Most recently, Mr Moyes served as vice president of finance and CFO at Myriad Genetics, a publicly traded molecular diagnostics and therapeutic development company. Prior to that, Mr Moyes served as CFO of Genmark, an agricultural biotechnology company, and as a CPA with the international public accounting firm of KPMG.
Mr Moyes received his BA in economics from Weber State University and his MBA from the University of Utah.
Pierre Cassigneul, president and CEO of XDx, said: “Jay’s business acumen, combined with his appreciation of the importance of technology that improves the patient experience and outcome potential, will help XDx as we continue to develop and grow our business.”